Watch a scientific symposium presentation from Harvard Medical School and Massachusetts General Hospital researcher Dr. Leif Ellisen exploring the haploinsufficient phenotypes observed in BRCA1/2-mutant breast tissue, delivered at the 2023 Dana-Farber Cancer Institute Center for BRCA and Related Genes Scientific Symposium. Gain insights into the latest research findings regarding BRCA gene mutations and their effects on breast tissue development and cancer risk through this detailed 42-minute scientific talk aimed at medical professionals and researchers in the field of cancer genetics.
Haploinsufficient Phenotypes of BRCA1/2-Mutant Breast Tissue - 2023
Dana-Farber Cancer Institute via YouTube
Overview
Syllabus
Haploinsufficient Phenotypes of BRCA1/2-Mutant Breast Tissue | 2023 BRCA Scientific Symposium
Taught by
Dana-Farber Cancer Institute
Related Courses
-
Synthetic Lethal Interactions of BRCA1 in Stalled-Fork Repair - 2023
-
DDR Deficiency and Replication Stress as Therapeutic Targets for Pancreatic Cancer - 2023
-
Health Literacy and Barriers to Engaging People in Clinical Trials - 2023
-
Genetic Testing for Breast Cancer Susceptibility - Webinar - Ambry Genetics
-
Classical papers in molecular genetics
-
How Tissue and Liquid Biopsies Are Used in Metastatic Breast Cancer Treatment - 2022-2023
